1
|
Guilleminot P, Graef C, Butters E, Reichenbach T. Audiotactile Stimulation Can Improve Syllable Discrimination through Multisensory Integration in the Theta Frequency Band. J Cogn Neurosci 2023; 35:1760-1772. [PMID: 37677062 DOI: 10.1162/jocn_a_02045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/09/2023]
Abstract
Syllables are an essential building block of speech. We recently showed that tactile stimuli linked to the perceptual centers of syllables in continuous speech can improve speech comprehension. The rate of syllables lies in the theta frequency range, between 4 and 8 Hz, and the behavioral effect appears linked to multisensory integration in this frequency band. Because this neural activity may be oscillatory, we hypothesized that a behavioral effect may also occur not only while but also after this activity has been evoked or entrained through vibrotactile pulses. Here, we show that audiotactile integration regarding the perception of single syllables, both on the neural and on the behavioral level, is consistent with this hypothesis. We first stimulated participants with a series of vibrotactile pulses and then presented them with a syllable in background noise. We show that, at a delay of 200 msec after the last vibrotactile pulse, audiotactile integration still occurred in the theta band and syllable discrimination was enhanced. Moreover, the dependence of both the neural multisensory integration as well as of the behavioral discrimination on the delay of the audio signal with respect to the last tactile pulse was consistent with a damped oscillation. In addition, the multisensory gain is correlated with the syllable discrimination score. Our results therefore evidence the role of the theta band in audiotactile integration and provide evidence that these effects may involve oscillatory activity that still persists after the tactile stimulation.
Collapse
|
2
|
Varano E, Guilleminot P, Reichenbach T. AVbook, a high-frame-rate corpus of narrative audiovisual speech for investigating multimodal speech perception. J Acoust Soc Am 2023; 153:3130. [PMID: 37249407 DOI: 10.1121/10.0019460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Accepted: 05/01/2023] [Indexed: 05/31/2023]
Abstract
Seeing a speaker's face can help substantially with understanding their speech, particularly in challenging listening conditions. Research into the neurobiological mechanisms behind audiovisual integration has recently begun to employ continuous natural speech. However, these efforts are impeded by a lack of high-quality audiovisual recordings of a speaker narrating a longer text. Here, we seek to close this gap by developing AVbook, an audiovisual speech corpus designed for cognitive neuroscience studies and audiovisual speech recognition. The corpus consists of 3.6 h of audiovisual recordings of two speakers, one male and one female, each reading 59 passages from a narrative English text. The recordings were acquired at a high frame rate of 119.88 frames/s. The corpus includes phone-level alignment files and a set of multiple-choice questions to test attention to the different passages. We verified the efficacy of these questions in a pilot study. A short written summary is also provided for each recording. To enable audiovisual synchronization when presenting the stimuli, four videos of an electronic clapperboard were recorded with the corpus. The corpus is publicly available to support research into the neurobiology of audiovisual speech processing as well as the development of computer algorithms for audiovisual speech recognition.
Collapse
Affiliation(s)
- Enrico Varano
- Department of Bioengineering and Centre for Neurotechnology, Imperial College London, London, United Kingdom
| | - Pierre Guilleminot
- Department of Bioengineering and Centre for Neurotechnology, Imperial College London, London, United Kingdom
| | - Tobias Reichenbach
- Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| |
Collapse
|
3
|
Hamdan R, Guilleminot P, Leclercq T, Monin A. Coronary-subclavian steal syndrome causing myocardial infarction after arteriovenous fistula creation: a case report. ESC Heart Fail 2023; 10:2084-2089. [PMID: 36871950 DOI: 10.1002/ehf2.14341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2022] [Revised: 02/14/2023] [Accepted: 02/24/2023] [Indexed: 03/07/2023] Open
Abstract
Coronary subclavian steal syndrome (CSSS) caused by left subclavian artery (LSA) stenosis is a rare cause of myocardial infarction in patients having coronary artery bypass grafting (CABG), and it has also been observed after an arteriovenous fistula (AVF) was made. A 79-year-old woman who had undergone CABG years earlier and an AVF creation 1 month before experienced a non-ST-elevation myocardial infarction (NSTEMI). While selective catheterization of the left internal thoracic artery graft was impossible, a computed tomography scanner showed patency of all bypasses and proximal subocclusive LSA stenosis, and the digital blood pressure measurements objectified a haemodialysis-induced distal ischaemia. LSA's angioplasty and covered stent placement were successfully performed, resulting in symptom remission. A CSSS-induced NSTEMI due to a LSA stenosis aggravated by a homolateral AVF several years after CABG has been documented only infrequently. If vascular access is required in the presence of CSSS risk factors, the contralateral upper limb should be preferred.
Collapse
Affiliation(s)
- Rémy Hamdan
- Department of Angiology, Dijon Bourgogne University Hospital, Dijon, France
| | - Pierre Guilleminot
- Department of Cardiology, Dijon Bourgogne University Hospital, Dijon, France
| | - Thibault Leclercq
- Department of Cardiology, Dijon Bourgogne University Hospital, Dijon, France
| | - Antoine Monin
- Department of Cardiology, Dijon Bourgogne University Hospital, Dijon, France
| |
Collapse
|
4
|
Weizman O, Duceau B, Trimaille A, Pommier T, Cellier J, Geneste L, Panagides V, Marsou W, Deney A, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Karsenty C, Giordano G, Gautier A, Chaumont C, Guilleminot P, Sagnard A, Pastier J, Ezzouhairi N, Perin B, Zakine C, Levasseur T, Ma I, Chavignier D, Noirclerc N, Darmon A, Mevelec M, Sutter W, Mika D, Fauvel C, Pezel T, Waldmann V, Cohen A, Bonnet G. Machine learning-based scoring system to predict in-hospital outcomes in patients hospitalized with COVID-19. Arch Cardiovasc Dis 2022; 115:617-626. [PMID: 36376208 PMCID: PMC9595484 DOI: 10.1016/j.acvd.2022.08.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/12/2022] [Revised: 07/19/2022] [Accepted: 08/01/2022] [Indexed: 02/01/2023]
Abstract
BACKGROUND The evolution of patients hospitalized with coronavirus disease 2019 (COVID-19) is still hard to predict, even after several months of dealing with the pandemic. AIMS To develop and validate a score to predict outcomes in patients hospitalized with COVID-19. METHODS All consecutive adults hospitalized for COVID-19 from February to April 2020 were included in a nationwide observational study. Primary composite outcome was transfer to an intensive care unit from an emergency department or conventional ward, or in-hospital death. A score that estimates the risk of experiencing the primary outcome was constructed from a derivation cohort using stacked LASSO (Least Absolute Shrinkage and Selection Operator), and was tested in a validation cohort. RESULTS Among 2873 patients analysed (57.9% men; 66.6±17.0 years), the primary outcome occurred in 838 (29.2%) patients: 551 (19.2%) were transferred to an intensive care unit; and 287 (10.0%) died in-hospital without transfer to an intensive care unit. Using stacked LASSO, we identified 11 variables independently associated with the primary outcome in multivariable analysis in the derivation cohort (n=2313), including demographics (sex), triage vitals (body temperature, dyspnoea, respiratory rate, fraction of inspired oxygen, blood oxygen saturation) and biological variables (pH, platelets, C-reactive protein, aspartate aminotransferase, estimated glomerular filtration rate). The Critical COVID-19 France (CCF) risk score was then developed, and displayed accurate calibration and discrimination in the derivation cohort, with C-statistics of 0.78 (95% confidence interval 0.75-0.80). The CCF risk score performed significantly better (i.e. higher C-statistics) than the usual critical care risk scores. CONCLUSIONS The CCF risk score was built using data collected routinely at hospital admission to predict outcomes in patients with COVID-19. This score holds promise to improve early triage of patients and allocation of healthcare resources.
Collapse
Affiliation(s)
- Orianne Weizman
- Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-lès-Nancy, France,Université de Paris, PARCC, INSERM, 75015 Paris, France
| | | | - Antonin Trimaille
- Nouvel Hopital Civil, Centre Hospitalier Régional Universitaire de Strasbourg, 67000 Strasbourg, France
| | - Thibaut Pommier
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France
| | - Joffrey Cellier
- Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France
| | - Laura Geneste
- Centre Hospitalier Universitaire d’Amiens-Picardie, 80000 Amiens, France
| | - Vassili Panagides
- Centre Hospitalier Universitaire de Marseille, 13005 Marseille, France
| | - Wassima Marsou
- GCS-Groupement des Hôpitaux de l’Institut Catholique de Lille, Faculté de Médecine et de Maïeutique, Université Catholique de Lille, 59800 Lille, France
| | - Antoine Deney
- Centre Hospitalier Universitaire de Toulouse, 31400 Toulouse, France
| | - Sabir Attou
- Centre Hospitalier Universitaire de Caen-Normandie, 14000 Caen, France
| | - Thomas Delmotte
- Centre Hospitalier Universitaire de Reims, 51100 Reims, France
| | | | | | - Clément Karsenty
- Centre Hospitalier Universitaire de Toulouse, 31400 Toulouse, France
| | - Gauthier Giordano
- Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-lès-Nancy, France
| | | | - Corentin Chaumont
- Centre Hospitalier Universitaire de Rouen, FHU REMOD-VHF, 76000 Rouen, France
| | | | - Audrey Sagnard
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France
| | - Julie Pastier
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France
| | - Nacim Ezzouhairi
- Centre Hospitalier Universitaire de Bordeaux, 33076 Bordeaux, France
| | - Benjamin Perin
- Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-lès-Nancy, France
| | - Cyril Zakine
- Clinique Saint-Gatien, 37540 Saint-Cyr-sur-Loire, France
| | - Thomas Levasseur
- Centre Hospitalier Intercommunal Fréjus-Saint-Raphaël, 83600 Fréjus, France
| | - Iris Ma
- Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France
| | | | | | - Arthur Darmon
- Hôpital Bichat-Claude-Bernard, AP–HP, Université de Paris, 75018 Paris, France
| | - Marine Mevelec
- Centre Hospitalier Régional de Orléans, 45100 Orléans, France
| | - Willy Sutter
- Université de Paris, PARCC, INSERM, 75015 Paris, France
| | - Delphine Mika
- Université Paris-Saclay, Inserm, UMR-S 1180, 92296 Chatenay-Malabry, France
| | - Charles Fauvel
- Centre Hospitalier Universitaire de Rouen, FHU REMOD-VHF, 76000 Rouen, France
| | - Théo Pezel
- Hôpital Lariboisière, AP–HP, Université de Paris, 75010 Paris, France
| | - Victor Waldmann
- Université de Paris, PARCC, INSERM, 75015 Paris, France,Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France
| | - Ariel Cohen
- Hôpital Saint-Antoine, 75012 Paris, France,Corresponding author. Hôpital Saint-Antoine, 184, Rue du Faubourg Saint-Antoine, 75012 Paris, France
| | - Guillaume Bonnet
- Université de Paris, PARCC, INSERM, 75015 Paris, France,Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France
| | | |
Collapse
|
5
|
Trimaille A, Ribeyrolles S, Fauvel C, Chaumont C, Weizman O, Pommier T, Cellier J, Geneste L, Panagides V, Marsou W, Deney A, Attou S, Delmotte T, Chemaly P, Karsenty C, Giordano G, Gautier A, Guilleminot P, Sagnard A, Pastier J, Duceau B, Sutter W, Waldmann V, Pezel T, Mika D, Cohen A, Bonnet G. Cardiovascular Characteristics and Outcomes of Young Patients with COVID-19. J Cardiovasc Dev Dis 2021; 8:jcdd8120165. [PMID: 34940520 PMCID: PMC8704739 DOI: 10.3390/jcdd8120165] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2021] [Revised: 11/14/2021] [Accepted: 11/21/2021] [Indexed: 01/10/2023] Open
Abstract
Although 18–45-year-old (y-o) patients represent a significant proportion of patients hospitalized for COVID-19, data concerning the young population remain scarce. The Critical COVID France (CCF) study was an observational study including consecutive patients hospitalized for COVID-19 in 24 centers between 26 February and 20 April 2020. The primary composite outcome included transfer to the intensive care unit (ICU) or in-hospital death. Secondary outcomes were cardiovascular (CV) complications. Among 2868 patients, 321 (11.2%) patients were in the 18–45-y-o range. In comparison with older patients, young patients were more likely to have class 2 obesity and less likely to have hypertension, diabetes and dyslipidemia. The primary outcome occurred less frequently in 18–45-y-o patients in comparison with patients > 45 years old (y/o) (16.8% vs. 30.7%, p < 0.001). The 18–45-y-o patients presented with pericarditis (2.2% vs. 0.5%, p = 0.003) and myocarditis (2.5% vs. 0.6%, p = 0.002) more frequently than patients >45 y/o. Acute heart failure occurred less frequently in 18–45-y-o patients (0.9% vs. 7.2%, p < 0.001), while thrombotic complications were similar in young and older patients. Whereas both transfer to the ICU and in-hospital death occurred less frequently in young patients, COVID-19 seemed to have a particular CV impact in this population.
Collapse
Affiliation(s)
- Antonin Trimaille
- Centre Hospitalier Régional Universitaire de Strasbourg, 67000 Strasbourg, France;
| | | | - Charles Fauvel
- Centre Hospitalier Universitaire de Rouen, 76000 Rouen, France; (C.F.); (C.C.)
| | - Corentin Chaumont
- Centre Hospitalier Universitaire de Rouen, 76000 Rouen, France; (C.F.); (C.C.)
| | - Orianne Weizman
- Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandœuvre-Lès-Nancy, France; (O.W.); (G.G.)
| | - Thibaut Pommier
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France; (T.P.); (P.G.); (A.S.); (J.P.)
| | - Joffrey Cellier
- Hôpital Européen Georges Pompidou, Université de Paris, 75015 Paris, France; (J.C.); (W.S.); (V.W.)
| | - Laura Geneste
- Centre Hospitalier Universitaire d’Amiens-Picardie, 80000 Amiens, France;
| | - Vassili Panagides
- Centre Hospitalier Universitaire de Marseille, 13005 Marseille, France;
| | - Wassima Marsou
- Faculté de Médecine et de Maïeutique, GCS-Groupement des Hôpitaux de l’Institut Catholique de Lille, Université Catholique de Lille, 59800 Lille, France;
| | - Antoine Deney
- Centre Hospitalier Universitaire de Toulouse, 31400 Toulouse, France; (A.D.); (C.K.)
| | - Sabir Attou
- Centre Hospitalier Universitaire de Caen-Normandie, 14000 Caen, France;
| | - Thomas Delmotte
- Centre Hospitalier Universitaire de Reims, 51100 Reims, France;
| | - Pascale Chemaly
- Institut Cardiovasculaire Paris Sud, Massy, 91300 Paris, France; (P.C.); (A.G.)
| | - Clément Karsenty
- Centre Hospitalier Universitaire de Toulouse, 31400 Toulouse, France; (A.D.); (C.K.)
| | - Gauthier Giordano
- Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandœuvre-Lès-Nancy, France; (O.W.); (G.G.)
| | - Alexandre Gautier
- Institut Cardiovasculaire Paris Sud, Massy, 91300 Paris, France; (P.C.); (A.G.)
| | - Pierre Guilleminot
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France; (T.P.); (P.G.); (A.S.); (J.P.)
| | - Audrey Sagnard
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France; (T.P.); (P.G.); (A.S.); (J.P.)
| | - Julie Pastier
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France; (T.P.); (P.G.); (A.S.); (J.P.)
| | - Baptiste Duceau
- Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Université de Paris, 75015 Paris, France; (B.D.); (G.B.)
| | - Willy Sutter
- Hôpital Européen Georges Pompidou, Université de Paris, 75015 Paris, France; (J.C.); (W.S.); (V.W.)
- Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Université de Paris, 75015 Paris, France; (B.D.); (G.B.)
| | - Victor Waldmann
- Hôpital Européen Georges Pompidou, Université de Paris, 75015 Paris, France; (J.C.); (W.S.); (V.W.)
- Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Université de Paris, 75015 Paris, France; (B.D.); (G.B.)
| | - Théo Pezel
- Hôpital Lariboisière, APHP, Université de Paris, 75010 Paris, France;
| | - Delphine Mika
- Signaling and Cardiovascular Pathophysiology, Inserm, UMR-S 1180, Université Paris-Saclay, Chatenay-Malabry, 92296 Paris, France;
| | - Ariel Cohen
- Hôpital Saint Antoine, 75012 Paris, France
- Correspondence:
| | - Guillaume Bonnet
- Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Université de Paris, 75015 Paris, France; (B.D.); (G.B.)
- Unité Médico-Chirurgicale de Valvulopathies et Cardiomyopathies, Université de Bordeaux, Hopital Cardiologique Haut-Lévêque, 33600 Pessac, France
| | | |
Collapse
|
6
|
Shafti A, Haar S, Mio R, Guilleminot P, Faisal AA. Playing the piano with a robotic third thumb: assessing constraints of human augmentation. Sci Rep 2021; 11:21375. [PMID: 34725355 PMCID: PMC8560761 DOI: 10.1038/s41598-021-00376-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2021] [Accepted: 10/05/2021] [Indexed: 11/16/2022] Open
Abstract
Contemporary robotics gives us mechatronic capabilities for augmenting human bodies with extra limbs. However, how our motor control capabilities pose limits on such augmentation is an open question. We developed a Supernumerary Robotic 3rd Thumbs (SR3T) with two degrees-of-freedom controlled by the user’s body to endow them with an extra contralateral thumb on the hand. We demonstrate that a pianist can learn to play the piano with 11 fingers within an hour. We then evaluate 6 naïve and 6 experienced piano players in their prior motor coordination and their capability in piano playing with the robotic augmentation. We show that individuals’ augmented performance with the SR3T could be explained by our new custom motor coordination assessment, the Human Augmentation Motor Coordination Assessment (HAMCA) performed pre-augmentation. Our work demonstrates how supernumerary robotics can augment humans in skilled tasks and that individual differences in their augmentation capability are explainable by their individual motor coordination abilities.
Collapse
Affiliation(s)
- Ali Shafti
- Brain and Behaviour Laboratory, Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK.,Department of Computing, Imperial College London, London, SW7 2AZ, UK.,Behaviour Analytics Laboratory, Data Science Institute, London, SW7 2AZ, UK
| | - Shlomi Haar
- Brain and Behaviour Laboratory, Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK.,Behaviour Analytics Laboratory, Data Science Institute, London, SW7 2AZ, UK.,Department of Brain Sciences and UK Dementia Research Institute - Care Research and Technology Centre, Imperial College London, London, W12 0BZ, UK
| | - Renato Mio
- Brain and Behaviour Laboratory, Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK
| | - Pierre Guilleminot
- Brain and Behaviour Laboratory, Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK
| | - A Aldo Faisal
- Brain and Behaviour Laboratory, Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK. .,Department of Computing, Imperial College London, London, SW7 2AZ, UK. .,Behaviour Analytics Laboratory, Data Science Institute, London, SW7 2AZ, UK. .,UKRI CDT in AI for Healthcare, Imperial College London, London, SW7 2AZ, UK. .,MRC London Institute of Medical Sciences, London, W12 0NN, UK.
| |
Collapse
|
7
|
Weizman O, Mika D, Cellier J, Geneste L, Trimaille A, Pommier T, Panagides V, Marsou W, Deney A, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Karsenty C, Giordano G, Gautier A, Chaumont C, Guilleminot P, Sagnard A, Pastier J, Duceau B, Sutter W, Fauvel C, Pezel T, Bonnet G, Cohen A, Waldmann V. Characteristics and impact of cardiovascular comorbidities on coronavirus disease 2019 in women: A multicentre cohort study. Arch Cardiovasc Dis 2021; 114:394-406. [PMID: 34154954 PMCID: PMC8139232 DOI: 10.1016/j.acvd.2021.04.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Revised: 03/23/2021] [Accepted: 04/13/2021] [Indexed: 01/10/2023]
Abstract
Background Although women account for up to half of patients hospitalized for coronavirus disease 2019 (COVID-19), no specific data have been reported in this population. Aims To assess the burden and impact of cardiovascular comorbidities in women with COVID-19. Methods All consecutive patients hospitalized for COVID-19 across 24 hospitals from 26 February to 20 April 2020 were included. The primary composite outcome was transfer to an intensive care unit or in-hospital death. Results Among 2878 patients, 1212 (42.1%) were women. Women were older (68.3 ± 18.0 vs. 65.4 ± 16.0 years; P < 0.001), but had less prevalent cardiovascular comorbidities than men. Among women, 276 (22.8%) experienced the primary outcome, including 161 (13.3%) transfers to an intensive care unit and 115 (9.5%) deaths without transfer to intensive care unit. The rate of in-hospital death or transfer to an intensive care unit was lower in women versus men (crude hazard ratio [HR]: 0.62, 95% confidence interval [CI]: 0.53–0.72). Age (adjusted HR: 1.05 per 5-year increase, 95% CI: 1.01–1.10), body mass index (adjusted HR: 1.06 per 2-unit increase, 95% CI: 1.02–1.10), chronic kidney disease (adjusted HR: 1.57, 95% CI: 1.11–2.22) and heart failure (adjusted HR: 1.52, 95% CI: 1.04–2.22) were independently associated with the primary outcome in women. Elevated B-type natriuretic peptide/N-terminal prohormone of B-type natriuretic peptide (adjusted HR: 2.41, 95% CI: 1.70–3.44) and troponin (adjusted HR: 2.00, 95% CI: 1.39–2.88) concentrations at admission were also associated with the primary outcome, even in women free of previous coronary artery disease or heart failure. Conclusions Although female sex was associated with a lower risk of transfer to an intensive care unit or in-hospital death, COVID-19 remained associated with considerable morbimortality in women, especially in those with cardiovascular diseases.
Collapse
Affiliation(s)
- Orianne Weizman
- Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandœuvre-Les-Nancy, France; Université de Paris, PARCC, INSERM, 75015 Paris, France
| | - Delphine Mika
- Université Paris-Saclay, INSERM, UMR-S 1180, 92296 Châtenay-Malabry, France
| | - Joffrey Cellier
- Hôpital Européen Georges-Pompidou, AP-HP, Université de Paris, 75015 Paris, France
| | - Laura Geneste
- Centre Hospitalier Universitaire d'Amiens-Picardie, 80000 Amiens, France
| | - Antonin Trimaille
- Nouvel Hôpital Civil, Centre Hospitalier Régional Universitaire de Strasbourg, 67000 Strasbourg, France
| | - Thibaut Pommier
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France
| | - Vassili Panagides
- Centre Hospitalier Universitaire de Marseille, 13005 Marseille, France
| | - Wassima Marsou
- GCS-Groupement des Hôpitaux de l'Institut Catholique de Lille, Faculté de Médecine et de Maïeutique, Université Catholique de Lille, Lille, France
| | - Antoine Deney
- Centre Hospitalier Universitaire de Toulouse, 31400 Toulouse, France
| | - Sabir Attou
- Centre Hospitalier Universitaire de Caen-Normandie, 14000 Caen, France
| | - Thomas Delmotte
- Centre Hospitalier Universitaire de Reims, 51100 Reims, France
| | | | | | - Clément Karsenty
- Centre Hospitalier Universitaire de Toulouse, 31400 Toulouse, France
| | - Gauthier Giordano
- Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandœuvre-Les-Nancy, France
| | | | | | | | - Audrey Sagnard
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France
| | - Julie Pastier
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France
| | | | - Willy Sutter
- Université de Paris, PARCC, INSERM, 75015 Paris, France
| | - Charles Fauvel
- Rouen University Hospital, FHU REMOD-VHF, 76000 Rouen, France
| | - Théo Pezel
- Hôpital Lariboisiere, AP-HP, University of Paris, 75010 Paris, France
| | - Guillaume Bonnet
- Université de Paris, PARCC, INSERM, 75015 Paris, France; University of Bordeaux, Hôpital Cardiologique Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - Ariel Cohen
- Hôpital Saint-Antoine, AP-HP, 75012 Paris, France.
| | - Victor Waldmann
- Université de Paris, PARCC, INSERM, 75015 Paris, France; Hôpital Européen Georges-Pompidou, AP-HP, Université de Paris, 75015 Paris, France
| | | |
Collapse
|
8
|
Soulat-Dufour L, Fauvel C, Weizman O, Barbe T, Pezel T, Mika D, Cellier J, Geneste L, Panagides V, Marsou W, Deney A, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Karsenty C, Giordano G, Gautier A, Duceau B, Sutter W, Chaumont C, Guilleminot P, Sagnard A, Pastier J, Trimaille A, Bonnet G, Canu M, Coisne A, Cohen A. Prognostic value of right ventricular dilatation in patients with COVID-19: a multicentre study. Eur Heart J Cardiovasc Imaging 2021; 23:569-577. [PMID: 34008835 PMCID: PMC8600376 DOI: 10.1093/ehjci/jeab067] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/23/2020] [Accepted: 03/30/2021] [Indexed: 02/07/2023] Open
Abstract
Aims Although cardiac involvement has prognostic significance in coronavirus disease 2019 (COVID-19) and is associated with severe forms, few studies have explored the prognostic role of transthoracic echocardiography (TTE). We investigated the link between TTE parameters and prognosis in COVID-19. Methods and results Consecutive patients with COVID-19 admitted to 24 French hospitals were retrospectively included. Comprehensive data, including clinical and biological parameters, were recorded at admission. Focused TTE was performed during hospitalization, according to clinical indication. Patients were followed for a primary composite outcome of death or transfer to intensive care unit (ICU) during hospitalization. Among 2878 patients, 445 (15%) underwent TTE. Most of these had cardiovascular risk factors, a history of cardiovascular disease, and were on cardiovascular treatments. Dilatation and dysfunction were observed in, respectively, 12% (48/412) and 23% (102/442) of patients for the left ventricle, and in 12% (47/407) and 16% (65/402) for the right ventricle (RV). Primary composite outcome occurred in 44% (n = 196) of patients [9% (n = 42) for death without ICU transfer and 35% (n = 154) for admission to ICU]. RV dilatation was the only TTE parameter associated with the primary outcome. After adjustment, male sex [hazard ratio (HR) 1.56, 95% confidence interval (CI) 1.09 − 2.25; P = 0.02], higher body mass index (HR 1.10, 95% CI 1.02 − 1.18; P = 0.01), anticoagulation (HR 0.53, 95% CI 0.33 − 0.86; P = 0.01), and RV dilatation (HR 1.66, 95% CI 1.05 − 2.64; P = 0.03) remained independently associated with the primary outcome. Conclusion Echocardiographic evaluation of RV dilatation could be useful for assessing risk of severe COVID-19 developing in hospitalized patients.
Collapse
Affiliation(s)
- Laurie Soulat-Dufour
- Department of Cardiology, Saint Antoine and Tenon Hospital, AP-HP, INSERM UMRS-ICAN 1166 and Sorbonne Université, Paris, France
| | - Charles Fauvel
- Department of Cardiology, Rouen University Hospital, FHU REMOD-VHF, F76000 Rouen, France
| | - Orianne Weizman
- Department of Cardiology, Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France.,Université de Paris, PARCC, INSERM, 75015 Paris, France
| | - Thomas Barbe
- Department of Cardiology, Rouen University Hospital, FHU REMOD-VHF, F76000 Rouen, France
| | - Théo Pezel
- Department of Cardiology, Lariboisiere Hospital, APHP, University of Paris, 75010 Paris, France
| | - Delphine Mika
- Université Paris-Saclay, Inserm, UMR-S 1180, 92296 Chatenay-Malabry, France
| | - Joffrey Cellier
- Department of Cardiology, Hôpital Européen Georges Pompidou, Université de Paris, 75015 Paris, France
| | - Laura Geneste
- Department of Cardiology, Centre Hospitalier Universitaire d'Amiens-Picardie, 80000 Amiens, France
| | - Vassili Panagides
- Department of Cardiology, Aix-Marseille Université, Intensive care unit, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Marseille, France
| | - Wassima Marsou
- Department of Cardiology, GCS-Groupement des Hôpitaux de l'Institut Catholique de Lille, Faculté de Médecine et de Maïeutique, Université Catholique de Lille, Lille, France
| | - Antoine Deney
- Departement of Cardiology, Rangueil University Hospital, Toulouse, France" et "Institute of Cardiovascular and Metabolic Diseases, National Institute of Health and Medical Research (INSERM), UMR-1048 Toulouse, France
| | - Sabir Attou
- Department of Cardiology, Centre Hospitalier Universitaire de Caen-Normandie, 14000 Caen, France
| | - Thomas Delmotte
- Department of Cardiology, Centre Hospitalier Universitaire de Reims, 51100 Reims, France
| | - Sophie Ribeyrolles
- Department of Cardiology, Institut Mutualiste Montsouris, 75014 Paris, France
| | - Pascale Chemaly
- Department of Cardiology, Institut Cardiovasculaire Paris Sud, 91300 Massy, France
| | - Clement Karsenty
- Paediatric and Congenital Cardiology, Children's Hospital, CHU Toulouse, Institut des Maladies Métaboliques et Cardiovasculaires, Toulouse University, France
| | - Gauthier Giordano
- Department of Cardiology, Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France
| | - Alexandre Gautier
- Department of Cardiology, Institut Cardiovasculaire Paris Sud, 91300 Massy, France
| | | | - Willy Sutter
- Université de Paris, PARCC, INSERM, 75015 Paris, France
| | - Corentin Chaumont
- Department of Cardiology, Rouen University Hospital, FHU REMOD-VHF, F76000 Rouen, France
| | - Pierre Guilleminot
- Department of Cardiology, Centre Hospitalier Universitaire de Dijon, 21079 Dijon, France
| | - Audrey Sagnard
- Department of Cardiology, Centre Hospitalier Universitaire de Dijon, 21079 Dijon, France
| | - Julie Pastier
- Paediatric and Congenital Cardiology, Children's Hospital, CHU Toulouse, Institut des Maladies Métaboliques et Cardiovasculaires, Toulouse University, France
| | - Antonin Trimaille
- Department of Cardiology, Nouvel Hôpital Civil, Centre Hospitalier Régional Universitaire de Strasbourg, 67000 Strasbourg, France
| | - Guillaume Bonnet
- Université de Paris, PARCC, INSERM, 75015 Paris, France.,Department of Cardiology, Hôpital Européen Georges Pompidou, Université de Paris, 75015 Paris, France
| | - Marjorie Canu
- Department of Cardiology, University Hospital, CHU Grenoble, BP 217, 38043 Grenoble Cedex 09, France
| | - Augustin Coisne
- CHU Lille, Department of Clinical Physiology and Echocardiography-Heart Valve Center. University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France
| | - Ariel Cohen
- Department of Cardiology, Saint Antoine and Tenon Hospital, AP-HP, INSERM UMRS-ICAN 1166 and Sorbonne Université, Paris, France
| |
Collapse
|
9
|
Bonnet G, Weizman O, Trimaille A, Pommier T, Cellier J, Geneste L, Panagides V, Marsou W, Deney A, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Karsenty C, Giordano G, Gautier A, Chaumont C, Guilleminot P, Sagnard A, Pastiero J, Ezzouhairi N, Perin B, Zakine C, Levasseur T, Ma I, Chavignier D, Noirclerc N, Darmon A, Mevelec M, Duceau B, Sutter W, Mika D, Fauvel C, Pezel T, Waldmann V, Cohen A. Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study. Arch Cardiovasc Dis 2021; 114:352-363. [PMID: 34154953 PMCID: PMC7923854 DOI: 10.1016/j.acvd.2021.01.003] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2020] [Revised: 01/11/2021] [Accepted: 01/18/2021] [Indexed: 01/08/2023]
Abstract
Background The coronavirus disease 2019 (COVID-19) pandemic has led to a public health crisis. Only limited data are available on the characteristics and outcomes of patients hospitalized for COVID-19 in France. Aims To investigate the characteristics, cardiovascular complications and outcomes of patients hospitalized for COVID-19 in France. Methods The Critical COVID-19 France (CCF) study is a French nationwide study including all consecutive adults with a diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection hospitalized in 24 centres between 26 February and 20 April 2020. Patients admitted directly to intensive care were excluded. Clinical, biological and imaging parameters were systematically collected at hospital admission. The primary outcome was in-hospital death. Results Of 2878 patients included (mean ± SD age 66.6 ± 17.0 years, 57.8% men), 360 (12.5%) died in the hospital setting, of which 7 (20.7%) were transferred to intensive care before death. The majority of patients had at least one (72.6%) or two (41.6%) cardiovascular risk factors, mostly hypertension (50.8%), obesity (30.3%), dyslipidaemia (28.0%) and diabetes (23.7%). In multivariable analysis, older age (hazard ratio [HR] 1.05, 95% confidence interval [CI] 1.03 − 1.06; P < 0.001), male sex (HR 1.69, 95% CI 1.11 − 2.57; P = 0.01), diabetes (HR 1.72, 95% CI 1.12 − 2.63; P = 0.01), chronic kidney failure (HR 1.57, 95% CI 1.02 − 2.41; P = 0.04), elevated troponin (HR 1.66, 95% CI 1.11 − 2.49; P = 0.01), elevated B-type natriuretic peptide or N-terminal pro-B-type natriuretic peptide (HR 1.69, 95% CI 1.0004 − 2.86; P = 0.049) and quick Sequential Organ Failure Assessment score ≥ 2 (HR 1.71, 95% CI 1.12 − 2.60; P = 0.01) were independently associated with in-hospital death. Conclusions In this large nationwide cohort of patients hospitalized for COVID-19 in France, cardiovascular comorbidities and risk factors were associated with a substantial morbi-mortality burden.
Collapse
Affiliation(s)
- Guillaume Bonnet
- Université de Paris, PARCC, inserm, 75015 Paris, France; Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France
| | - Orianne Weizman
- Université de Paris, PARCC, inserm, 75015 Paris, France; Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France
| | - Antonin Trimaille
- Nouvel hopital Civil, Centre Hospitalier régional universitaire de Strasbourg, 67000 Strasbourg, France
| | - Thibaut Pommier
- Lariboisiere hospital, AP-HP, university of Paris, 75010 Paris, France; Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France
| | - Joffrey Cellier
- Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France
| | - Laura Geneste
- Centre Hospitalier universitaire d'Amiens-Picardie, 80000 Amiens, France
| | - Vassili Panagides
- Centre Hospitalier Universitaire de Marseille, 13005 Marseille, France
| | - Wassima Marsou
- GCS-Groupement des Hôpitaux de l'Institut Catholique de Lille, Faculté de Médecine et de Maïeutique, Université Catholique de Lille, Lille, France
| | - Antoine Deney
- Centre Hospitalier universitaire de Toulouse, 31400 Toulouse, France
| | - Sabir Attou
- Centre Hospitalier universitaire de Caen-Normandie, 14000 Caen, France
| | - Thomas Delmotte
- Centre Hospitalier universitaire de Reims, 51100 Reims, France
| | | | | | - Clément Karsenty
- Centre Hospitalier universitaire de Toulouse, 31400 Toulouse, France
| | - Gauthier Giordano
- Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France
| | | | | | | | - Audrey Sagnard
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France
| | - Julie Pastiero
- Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France
| | - Nacim Ezzouhairi
- Centre Hospitalier universitaire de Bordeaux, 33076 Bordeaux, France
| | - Benjamin Perin
- Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France
| | - Cyril Zakine
- Clinique Saint-Gatien, 37540 Saint-Cyr-sur-Loire, France
| | - Thomas Levasseur
- Centre Hospitalier intercommunal Fréjus-Saint-Raphaël, 83600 Fréjus, France
| | - Iris Ma
- Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France
| | | | | | - Arthur Darmon
- Hôpital Bichat-Claude-Bernard, AP-HP, université de Paris, 75018 Paris, France
| | - Marine Mevelec
- Centre Hospitalier régional de Orléans, 45100 Orléans, France
| | - Baptiste Duceau
- Université de Paris, PARCC, inserm, 75015 Paris, France; Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France
| | - Willy Sutter
- Université de Paris, PARCC, inserm, 75015 Paris, France; Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France
| | - Delphine Mika
- Université Paris-Saclay, Inserm, UMR-S 1180, 92296 Chatenay-Malabry, France
| | - Charles Fauvel
- Rouen University Hospital, FHU REMOD-VHF, 76000 Rouen, France
| | - Théo Pezel
- Lariboisiere hospital, AP-HP, university of Paris, 75010 Paris, France
| | - Victor Waldmann
- Université de Paris, PARCC, inserm, 75015 Paris, France; Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France
| | - Ariel Cohen
- Hôpital Saint-Antoine, Saint-Antoine and Tenon hospitals, AP-HP, Inserm UMRS-ICAN 1166 Sorbonne-Université, French Society of Cardiology 2020-2022, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France.
| |
Collapse
|